Unknown

Dataset Information

Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trial.


ABSTRACT:

Introduction

Established personal and familial risk factors contribute collectively to a woman's risk of breast or ovarian cancer. Existing clinical services offer genetic testing for pathogenic variants in high-risk genes to investigate these risks but recent information on the role of common genomic variants, in the form of a Polygenic Risk Score (PRS), has provided the potential to further personalise breast and ovarian cancer risk assessment. Data from cohort studies support the potential of an integrated risk assessment to improve targeted risk management but experience of this approach in clinical practice is limited.

Methods and analysis

The polygenic risk modification trial is an Australian multicentre prospective randomised controlled trial of integrated risk assess

SUBMITTER: McInerny S 

PROVIDER: S-EPMC11308879 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature